Ontology highlight
ABSTRACT: Objective
This study aimed to analyze interaction between glycosaminoglycan-acemannan as a scaffold material and toll-like receptor-2 (TLR-2) receptor, which predicted the osteogenesis potency on alveolar bone healing (in silico analysis).Materials and methods
Docking interaction between glycosaminoglycan-acemannan and TLR-2 receptor using the Molegro Virtual Docker (MVD) program. The compounds of glycosaminoglycan-acemannan and TLR-2 receptor with the structure in the form of two- and three-dimensional images were analyzed, as well as the most stable structure. It was observed the interaction of the ligand on the cavity of the TLR-2 receptor structure. The energy required for the ligand and receptor interaction (Moldock score) was calculated with MPD program.Results
The chemical structure shows that glycosaminoglycan-acemannan is capable binding to the TLR-2 receptor with hydrogen bonds and strong steric interaction. The docking results were detected for five cavities where the compound binds to the TLR-2 receptor. The Moldock score of the ligand on the CAS-LYS-LEU-ARG-LYS-ILE-MSE[A] ligand was -95,58 Kcal/mol, that of acemannan was -91,96 Kcal/mol, and for glycosaminoglycan -61,14 Kcal/mol.Conclusion
The compound of glycosaminoglycan-acemannan as a scaffold material is able to bind with a TLR-2 target receptor, which predicted osteogenesis activity on alveolar bone healing supported by in silico analysis.
SUBMITTER: Sularsih S
PROVIDER: S-EPMC9507609 | biostudies-literature | 2022 Jul
REPOSITORIES: biostudies-literature
Sularsih Sularsih S Mulawarmanti Dian D Rahmitasari Fitria F Siswodihardjo Siswandono S
European journal of dentistry 20220422 3
<h4>Objective</h4> This study aimed to analyze interaction between glycosaminoglycan-acemannan as a scaffold material and toll-like receptor-2 (TLR-2) receptor, which predicted the osteogenesis potency on alveolar bone healing (<i>in silico</i> analysis).<h4>Materials and methods</h4> Docking interaction between glycosaminoglycan-acemannan and TLR-2 receptor using the <i>Molegro Virtual Docker</i> (MVD) program. The compounds of glycosaminoglycan-acemannan and TLR-2 receptor with the structure i ...[more]